ID3 mediates the TGF-β1-induced suppression of matrix metalloproteinase-1 in human granulosa cells

Hui Li, Hsun-Ming Chang, Zhendan Shi, Peter C K Leung, Hui Li, Hsun-Ming Chang, Zhendan Shi, Peter C K Leung

Abstract

In the mammalian ovary, matrix metalloproteinase-1 (MMP1) is expressed in growing ovarian follicles, and MMP1-mediated extracellular matrix (ECM) remodeling plays a functional role in regulating the formation of corpus luteum. Transforming growth factor-β1 (TGF-β1) is an intraovarian growth factor that acts as a negative regulator of luteinization and progesterone production in human granulosa-lutein (hGL) cells. At present, whether TGF-β1 regulates the expression of MMP1 and thus affects ECM remodeling during corpus luteum formation remains largely unknown. The aim of this study was to investigate the effects of TGF-β1 and the molecular mechanisms by which it regulates the expression of MMP1 in immortalized human granulosa cells lines (SVOG) and primary hGL cells (obtained from consenting patients undergoing IVF treatment). We used inhibition approaches including a competitive antagonist for endogenous TGF-β type II receptor, pharmacological inhibitors (SB431542 and dorsomorphin), and specific small interfering RNA-targeted knockdown of ALK5 type I receptor and SMAD4 to demonstrate that TGF-β1 downregulates the expression and production of MMP1 via a TβRII/ALK5-mediated SMAD-dependent signaling pathway in hGL cells. Additionally, our results show that the suppressive effect of TGF-β1 on the expression of MMP1 is mediated by a transcription factor, the inhibitor of differentiation 3 (ID3) protein. Our findings provide insights into the molecular interactions and mechanisms of TGF-β1 and ID3 during the regulation of MMP1 in hGL cells.

Keywords: ID3; TGF-β1; corpus luteum; extracellular matrix; matrix metalloproteinase-1; ovarian development.

© 2019 Federation of European Biochemical Societies.

References

    1. Frantz C, Stewart KM & Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123, 4195-4200.
    1. Rodgers RJ, van Wezel IL, Irving-Rodgers HF, Lavranos TC, Irvine CM & Krupa M (1999) Roles of extracellular matrix in follicular development. J Reprod Fertil Suppl 54, 343-352.
    1. Woodruff TK & Shea LD (2007) The role of the extracellular matrix in ovarian follicle development. Reprod Sci 14, 6-10.
    1. Curry TE Jr & Osteen KG (2003) The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24, 428-465.
    1. Smith MF, Ricke WA, Bakke LJ, Dow MP & Smith GW (2002) Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Mol Cell Endocrinol 191, 45-56.
    1. Walch K, Nagele F, Zeillinger R, Vytiska-Binstorfer E, Huber JC & Hefler LA (2005) A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the presence of polycystic ovary syndrome in Caucasian women. Fertil Steril 83, 1565-1567.
    1. Zhu G, Kang L, Wei Q, Cui X, Wang S, Chen Y & Jiang Y (2014) Expression and regulation of MMP1, MMP3, and MMP9 in the chicken ovary in response to gonadotropins, sex hormones, and TGFB1. Biol Reprod 90, 57.
    1. Rosewell KL, Al-Alem L, Zakerkish F, McCord L, Akin JW, Chaffin CL, Brannstrom M & Curry TE Jr (2015) Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin. Fertil Steril 103, 826-833.
    1. Puttabyatappa M, Irwin A, Martin JD, Mesquitta M, Veiga-Lopez A & Padmanabhan V (2017) Developmental programming: gestational exposure to excess testosterone alters expression of ovarian matrix metalloproteases and their target proteins. Reprod Sci 25, 882-892.
    1. Berisha B, Steffl M, Welter H, Kliem H, Meyer HH, Schams D & Amselgruber W (2008) Effect of the luteinising hormone surge on regulation of vascular endothelial growth factor and extracellular matrix-degrading proteinases and their inhibitors in bovine follicles. Reprod Fertil Dev 20, 258-268.
    1. Myers M, Gay E, McNeilly AS, Fraser HM & Duncan WC (2007) In vitro evidence suggests activin-A may promote tissue remodeling associated with human luteolysis. Endocrinology 148, 3730-3739.
    1. Fujihara M, Yamamizu K, Wildt DE & Songsasen N (2016) Expression pattern of matrix metalloproteinases changes during folliculogenesis in the cat ovary. Reproduction in domestic animals =Zuchthygiene 51, 717-725.
    1. Luddi A, Gori M, Marrocco C, Capaldo A, Pavone V, Bianchi L, Boschi L, Morgante G, Piomboni P & de Leo V (2018) Matrix metalloproteinases and their inhibitors in human cumulus and granulosa cells as biomarkers for oocyte quality estimation. Fertil Steril 109, 930-939.e3.
    1. Atabakhsh M, Khodadadi I, Amiri I, Mahjub H & Tavilani H (2018) Activity of matrix metalloproteinase 2 and 9 in follicular fluid and seminal plasma and its relation to embryo quality and fertilization rate. J Reprod Infertil 19, 140-145.
    1. Young KA, Hennebold JD & Stouffer RL (2002) Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle. Mol Hum Reprod 8, 833-840.
    1. Chaffin CL & Stouffer RL (1999) Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulosa cells: time course and steroid regulation. Biol Reprod 61, 14-21.
    1. Tadakuma H, Okamura H, Kitaoka M, Iyama K & Usuku G (1993) Association of immunolocalization of matrix metalloproteinase 1 with ovulation in hCG-treated rabbit ovary. J Reprod Fertil 98, 503-508.
    1. Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L & San Antonio JD (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 277, 4223-4231.
    1. Karsenty G & Park RW (1995) Regulation of type I collagen genes expression. Int Rev Immunol 12, 177-185.
    1. Kern B, Shen J, Starbuck M & Karsenty G (2001) Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276, 7101-7107.
    1. Zhang Y & Stefanovic B (2016) LARP6 meets collagen mRNA: specific regulation of type I collagen expression. Int J Mol Sci 17, 419.
    1. Chang SW, Shefelbine SJ & Buehler MJ (2012) Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J 102, 640-648.
    1. Morales TI, Woessner JF Jr, Marsh JM & LeMaire WJ (1983) Collagen, collagenase and collagenolytic activity in rat Graafian follicles during follicular growth and ovulation. Biochem Biophys Acta 756, 119-122.
    1. Hirsch B, Leonhardt S, Jarry H, Reich R, Tsafriri A & Wuttke W (1993) In vivo measurement of rat ovarian collagenolytic activities. Endocrinology 133, 2761-2765.
    1. Reich R, Daphna-Iken D, Chun SY, Popliker M, Slager R, Adelmann-Grill BC & Tsafriri A (1991) Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids. Endocrinology 129, 1869-1875.
    1. Lind AK, Weijdegard B, Dahm-Kahler P, Molne J, Sundfeldt K & Brannstrom M (2006) Collagens in the human ovary and their changes in the perifollicular stroma during ovulation. Acta Obstet Gynecol Scand 85, 1476-1484.
    1. Silvester LM & Luck MR (1999) Distribution of extracellular matrix components in the developing ruminant corpus luteum: a wound repair hypothesis for luteinization. J Reprod Fertil 116, 187-198.
    1. Borkakoti N (2000) Structural studies of matrix metalloproteinases. J Mol Med (Berl) 78, 261-268.
    1. Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN, Cabrera CV, Buskin JN, Hauschka SD, Lassar AB et al. (1989) Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537-544.
    1. Perk J, Iavarone A & Benezra R (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5, 603-614.
    1. Nio-Kobayashi J, Narayanan R, Giakoumelou S, Boswell L, Hogg K & Duncan WC (2013) Expression and localization of inhibitor of differentiation (ID) proteins during tissue and vascular remodelling in the human corpus luteum. Mol Hum Reprod 19, 82-92.
    1. Krieglstein K, Rufer M, Suter-Crazzolara C & Unsicker K (1995) Neural functions of the transforming growth factors beta. Int J Dev Neurosci 13, 301-315.
    1. Chegini N & Flanders KC (1992) Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology 130, 1707-1715.
    1. Fried G & Wramsby H (1998) Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy. Hum Reprod 13, 656-659.
    1. Roy SK & Kole AR (1998) Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles. Mol Hum Reprod 4, 207-214.
    1. Knight PG & Glister C (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction 132, 191-206.
    1. Fang L, Chang HM, Cheng JC, Leung PC & Sun YP (2014) TGF-β1 induces COX-2 expression and PGE2 production in human granulosa cells through Smad signaling pathways. J Clin Endocrinol Metab 99, E1217-E1226.
    1. Chen YC, Chang HM, Cheng JC, Tsai HD, Wu CH & Leung PC (2015) Transforming growth factor-β1 up-regulates connexin43 expression in human granulosa cells. Hum Reprod 30, 2190-2201.
    1. Fang Y, Chang HM, Cheng JC, Klausen C, Leung PC & Yang X (2016) Transforming growth factor-?21 increases lysyl oxidase expression by downregulating MIR29A in human granulosa lutein cells. Reproduction 152, 205-213.
    1. Li H, Chang HM, Shi Z & Leung PCK (2018) SNAIL mediates TGF-β1-induced downregulation of pentraxin 3 expression in human granulosa cells. Endocrinology 159, 1644-1657.
    1. Fang L, Chang HM, Cheng JC, Leung PC & Sun YP (2014) TGF-beta1 downregulates StAR expression and decreases progesterone production through Smad3 and ERK1/2 signaling pathways in human granulosa cells. J Clin Endocrinol Metab 99, E2234-E2243.
    1. Zheng X, Boerboom D & Carriere PD (2009) Transforming growth factor-beta1 inhibits luteinization and promotes apoptosis in bovine granulosa cells. Reproduction 137, 969-977.
    1. Goldman S & Shalev E (2004) MMPS and TIMPS in ovarian physiology and pathophysiology. Front Biosci 9, 2474-2483.
    1. Derynck R & Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
    1. Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H, Shimizu K, Takehara K, Cano A, Saitoh M et al. (2004) A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 11, 1092-1101.
    1. Smith MF, McIntush EW & Smith GW (1994) Mechanisms associated with corpus luteum development. J Anim Sci 72, 1857-1872.
    1. Foley CJ & Kuliopulos A (2014) Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP function. J Cell Physiol 229, 1875-1880.
    1. Chan YC, Roy S, Huang Y, Khanna S & Sen CK (2012) The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 287, 41032-41043.
    1. Foley CJ, Fanjul-Fernandez M, Bohm A, Nguyen N, Agarwal A, Austin K, Koukos G, Covic L, Lopez-Otin C & Kuliopulos A (2014) Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis. Oncogene 33, 2264-2272.
    1. Gopal SK, Greening DW, Zhu HJ, Simpson RJ & Mathias RA (2016) Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis. Sci Rep 6, 28321.
    1. Hogg K, Etherington SL, Young JM, McNeilly AS & Duncan WC (2010) Inhibitor of differentiation (Id) genes are expressed in the steroidogenic cells of the ovine ovary and are differentially regulated by members of the transforming growth factor-beta family. Endocrinology 151, 1247-1256.
    1. Norton JD, Deed RW, Craggs G & Sablitzky F (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 8, 58-65.
    1. Fineschi S, Reith W, Guerne PA, Dayer JM & Chizzolini C (2006) Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts. FASEB J 20, 562-564.
    1. Estrada-Gutierrez G, Cappello RE, Mishra N, Romero R, Strauss JF 3rd & Walsh SW (2011) Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction. Am J Pathol 178, 451-460.
    1. Bu S, Asano Y, Bujor A, Highland K, Hant F & Trojanowska M (2010) Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels. Arthritis Rheum 62, 2117-2126.
    1. Raja-Khan N, Urbanek M, Rodgers RJ & Legro RS (2014) The role of TGF-β in polycystic ovary syndrome. Reprod Sci 21, 20-31.
    1. Tal R, Seifer DB, Shohat-Tal A, Grazi RV & Malter HE (2013) Transforming growth factor-beta1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation. Fertil Steril 100, 538-543.
    1. Homburg R, Armar NA, Eshel A, Adams J & Jacobs HS (1988) Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 297, 1024-1026.
    1. Derynck R (1994) TGF-beta-receptor-mediated signaling. Trends Biochem Sci 19, 548-553.
    1. Cheng JC, Chang HM, Fang L, Sun YP & Leung PC (2015) TGF-β up-regulates connective tissue growth factor expression in human granulosa cells through Smad and ERK1/2 signaling pathways. PLoS ONE 10, e0126532.
    1. Chang HM, Cheng JC, Taylor E & Leung PC (2014) Oocyte-derived BMP15 but not GDF9 down-regulates connexin43 expression and decreases gap junction intercellular communication activity in immortalized human granulosa cells. Mol Hum Reprod 20, 373-383.
    1. Chang HM, Cheng JC, Klausen C, Taylor EL & Leung PC (2014) Effects of recombinant activins on steroidogenesis in human granulosa-lutein cells. J Clin Endocrinol Metab 99, E1922-E1932.
    1. Chang HM, Fang L, Cheng JC, Taylor EL, Sun YP & Leung PC (2016) Effects of growth differentiation factor 8 on steroidogenesis in human granulosa-lutein cells. Fertil Steril 105, 520-528.
    1. Lie BL, Leung E, Leung PC & Auersperg N (1996) Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol 120, 169-176.
    1. Chang HM, Qiao J & Leung PC (2016) Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors. Hum Reprod Update 23, 1-18.
    1. Chang HM, Klausen C & Leung PC (2013) Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells. Fertil Steril 100, 585-92.e1.
    1. Chang HM, Pan HH, Cheng JC, Zhu YM & Leung PCK (2016) Growth differentiation factor 8 suppresses cell proliferation by up-regulating CTGF expression in human granulosa cells. Mol Cell Endocrinol 422, 9-17.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다